Quick Takeaways
- FMR LLC filed SCHEDULE 13G/A for REGENERON PHARMACEUTICALS INC COMMON STOCK (REGN).
- Disclosed ownership: 3.2%.
- Date of event: 30 Jun 2025.
FMR LLC - 30 Jun 2025 SCHEDULE 13G/A Report for REGENERON PHARMACEUTICALS INC COMMON STOCK (REGN)
- Filing Manager
- FMR LLC
- Reporting Manager
- FMR LLC
- Symbol
- REGN
- Shares outstanding
- 104,986,330 shares
- Disclosed Ownership
- 3,359,563 shares
- Ownership
- 3.2%
- Form type
- SCHEDULE 13G/A
- Filing time
- 06 Aug 2025, 12:11:01 UTC
- Date of event
- 30 Jun 2025
- Previous filing
- 12 Feb 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"FMR LLC disclosed 3.2% ownership in REGENERON PHARMACEUTICALS INC COMMON STOCK (REGN) on 30 Jun 2025."
What Changed
- Previous schedule filing date: 12 Feb 2025.
- Current filing was accepted on 06 Aug 2025, 12:11.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| FMR LLC | 3.2% | 3,359,563 | 3,156,858 | 0 | Richard Bourgelas | Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* | |
| Abigail P. Johnson | 3.2% | 3,359,563 | 0 | 0 | Richard Bourgelas | Duly authorized under Power of Attorney effective as of May 23, 2023, by and on behalf of Abigail P. Johnson* |